Data as of Aug 29
| +0.86 / +2.16%|
The 9 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 53.00, with a high estimate of 70.00 and a low estimate of 10.00. The median estimate represents a +30.03% increase from the last price of 40.76.
The current consensus among 11 polled investment analysts is to Buy stock in Isis Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.